Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Management of Ocular Surface Disease in Cataract and Refractive Surgery Patients

  • Chapter
  • First Online:
Ocular Surface Disease

  • 905 Accesses

Abstract

The integrity of the ocular surface is paramount for proper vision. The ocular surface is a delicate microenvironment susceptible to a variety of insults. Small changes can have a large impact on visual function. The pathophysiology of OSD is multifactorial; treatment of OSD therefore typically requires a multifaceted approach for effective management. Thorough evaluation of ocular surface and eyelid health is of critical importance in cataract and refractive surgery candidates. Relatively simple diagnostic techniques and treatments may effectively determine the difference between a satisfied and unsatisfied patient postoperatively. Comorbid OSD increases the risk of complications and can impair surgical outcomes. Thus, preoperative signs and symptoms of OSD must be managed aggressively. Cataract and refractive surgery should be delayed until the patient demonstrates objective evidence of improvement, with reliable and repeatable preoperative measurements. Patients should be encouraged to adhere to the prescribed treatment regimen, and certain cases can require several months of preoperative therapy. OSD may also influence intraoperative management of patients and guide selection of postoperative eye drop regimens and follow-up care. Meticulous attention to the health of the ocular surface is essential to optimize the surgical result, ensure patient satisfaction, and enhance vision-related quality of life.

One specific point that may deserve additional emphasis is that given the variability of the tear film quality, multifocal lenses should be used with extreme caution in this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Trattler W, Reilly C, Goldberg D, et al. Cataract and dry eye: prospective health assessment of cataract patients ocular surface study. American Society of Cataract and Refractive Surgery annual meeting. San Diego, CA, USA; 2011.

    Google Scholar 

  2. Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol. 2009;23:65–73.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Li XM, Hu L, Hu J, et al. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007;26:S16–20.

    Article  PubMed  Google Scholar 

  4. Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013;8(11):e78657.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cha SH, Lee JS, Oum BS, Kim CD. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Exp Ophthalmol. 2004;32(2):180–4.

    Article  PubMed  Google Scholar 

  6. Lin JC, Rapuano CJ, Laibson PR, Eagle RC Jr, Cohen EJ. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol. 2000;118(8):1129–32.

    CAS  PubMed  Google Scholar 

  7. Han KE, Yoon SC, Ahn JM. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014;157(6):1144.e1–50.e1.

    Article  Google Scholar 

  8. Afsharkhamseh N, Movahedan A, Motahari H, Djalilian AR. Cataract surgery in patients with ocular surface disease: an update in clinical diagnosis and treatment. Saudi J Ophthalmol. 2014;28(3):164–7.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008;27(10):1142–7.

    Article  PubMed  Google Scholar 

  10. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75–92.

    Google Scholar 

  11. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(12):6125–30.

    Article  PubMed  Google Scholar 

  12. Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309–15.

    Article  PubMed  Google Scholar 

  13. Sambursky R, Davitt WF III, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013;131(1):24–8.

    Article  CAS  PubMed  Google Scholar 

  14. Speaker MG, Milch FA, The SMK. role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639–49.

    Article  CAS  PubMed  Google Scholar 

  15. Gao YY, Di Pascuale MA, Elizondo A, Tseng SC. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea. 2007;26(2):136–43.

    Article  PubMed  Google Scholar 

  16. Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31(4):396–404.

    Article  PubMed  Google Scholar 

  17. Geerling G, Tauber J, Baudouin C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52(4):2050–64.

    Article  PubMed  PubMed Central  Google Scholar 

  18. De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83(3):526–35.

    Article  PubMed  Google Scholar 

  19. Bhargava R, Kumar P, Kumar M, et al. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol. 2013;6(6):811–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Donnenfeld ED, Solomon R, Roberts CW, et al. Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation. J Cataract Refract Surg. 2010;36(7):1095–100.

    Article  PubMed  Google Scholar 

  21. Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol. 2005;139(2):242–6.

    Article  PubMed  Google Scholar 

  22. Tutt R, Bradley A, Begley C, Thibos LN. Optical and visual impact of tear break-up in human eyes. Invest Ophthalmol Vis Sci. 2000;41(13):4117–23.

    CAS  PubMed  Google Scholar 

  23. Montés-Micó R. Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg. 2007;33(9):1631–5.

    Article  PubMed  Google Scholar 

  24. Epitropoulos AT, Matossian C, Berdy GJ, et al. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg. 2015;41(8):1672–7.

    Article  PubMed  Google Scholar 

  25. Fine IH, Hoffman RS, Packer M. Profile of clear corneal cataract incisions demonstrated by ocular coherence tomography. J Cataract Refract Surg. 2007;33:94–7.

    Article  PubMed  Google Scholar 

  26. Donnenfeld E. Multicenter prospective evaluation of effects of cataract extraction and limbal relaxing incisions on corneal sensation and dry eye. American Society of Cataract and Refractive Surgery annual meeting. San Diego, CA; 2011.

    Google Scholar 

  27. Yu Y, Hua H, Wu M, et al. Evaluation of dry eye after femtosecond laser-assisted cataract surgery. J Cataract Refract Surg. 2015;41(12):2614–23.

    Article  PubMed  Google Scholar 

  28. Cetinkaya S, Mestan E, Acir NO, et al. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol. 2015;15:68.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chung YW, TH O, Chung SK. The effect of topical cyclosporine 0.05% on dry eye after cataract surgery. Korean J Ophthalmol. 2013;27(3):167–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Jeng BH, Halfpenny CP, Meisler DM, Stock EL. Management of focal limbal stem cell deficiency associated with soft contact lens wear. Cornea. 2011;30(1):18–23.

    Article  PubMed  Google Scholar 

  31. Yeniad B, Adam YS, Bilgin LK, Gözüm N. Effect of 30-day continuous wear of silicone hydrogel contact lenses on corneal thickness. Eye Contact Lens. 2004;30(1):6–9.

    Article  PubMed  Google Scholar 

  32. Bloomfield SE, Jakobiec FA, Theodore FH. Contact lens induced keratopathy: a severe complication extending the spectrum of keratoconjunctivitis in contact lens wearers. Ophthalmology. 1984;91(3):290–4.

    Article  CAS  PubMed  Google Scholar 

  33. Kim BY, Riaz KM, Bakhtiari P, et al. Medically reversible limbal stem cell disease: clinical features and management strategies. Ophthalmology. 2014;121(10):2053–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sindt CW, Longmuir RA. Contact lens strategies for the patient with dry eye. Ocul Surf. 2007;5(4):294–307.

    Article  PubMed  Google Scholar 

  35. Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci. 2006;47(4):1319–28.

    Article  PubMed  Google Scholar 

  36. Chan EH, Chen L, Yu F, Deng SX. Epithelial thinning in limbal stem cell deficiency. Am J Ophthalmol. 2015;160(4):669.e4–77.e4.

    Google Scholar 

  37. Pisella PJ, Malet F, Lejeune S, et al. Ocular surface changes induced by contact lens wear. Cornea. 2001;20:820–5.

    Article  CAS  PubMed  Google Scholar 

  38. EY Y, Leung A, Rao S, Lam DS. Effect of laser in situ keratomileusis on tear stability. Ophthalmology. 2000;107(12):2131–5.

    Article  Google Scholar 

  39. Leroux Les Jardins S. Contact lens wearers as candidates for LASIK surgery: two pitfalls to avoid. J Fr Ophtalmol. 2002;25(1):71–7.

    CAS  PubMed  Google Scholar 

  40. Espana EM, Grueterich M, Romano AC, et al. Idiopathic limbal stem cell deficiency. Ophthalmology. 2002;109(11):2004–10.

    Article  PubMed  Google Scholar 

  41. Sacchetti M, Lambiase A, Cortes M, et al. Clinical and cytological findings in limbal stem cell deficiency. Graefes Arch Clin Exp Ophthalmol. 2005;243(9):870–6.

    Article  PubMed  Google Scholar 

  42. Joussen AM, Poulaki V, Mitsiades N, et al. VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):117–23.

    Article  PubMed  Google Scholar 

  43. Chan EH, Chen L, Rao JY, Yu F, Deng SX. Limbal basal cell density decreases in limbal stem cell deficiency. Am J Ophthalmol. 2015;160(4):678.e4–84.e4.

    Google Scholar 

  44. Donshik PC. Giant papillary conjunctivitis. Trans Am Ophthalmol Soc. 1994;92:687–744.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Sun Y, Zhang R, Gadek TR, et al. Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118). J Ocul Pharmacol Ther. 2013;29:395–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Rosenthal P, Cotter J. The Boston Scleral Lens in the management of severe ocular surface disease. Ophthalmol Clin North Am. 2003;16:89–93.

    Article  PubMed  Google Scholar 

  47. Wilson SE, Lin DT, Klyce SD, Reidy JJ, Insler MS. Topographic changes in contact lens-induced corneal warpage. Ophthalmology. 1990;97(6):734–44.

    Article  CAS  PubMed  Google Scholar 

  48. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:93–107.

    Google Scholar 

  49. Versura P, Campos EC. Menopause and dry eye. A possible relationship. Gynecol Endocrinol. 2005;20(5):289–98.

    Article  PubMed  Google Scholar 

  50. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286(17):2114–9.

    Article  CAS  PubMed  Google Scholar 

  51. Erdem U, Ozdegirmenci O, Sobaci E, et al. Dry eye in post-menopausal women using hormone replacement therapy. Maturitas. 2007;56(3):257–62.

    Article  CAS  PubMed  Google Scholar 

  52. Leyland M, Zinicola E. Multifocal versus monofocal intraocular lenses in cataract surgery: a systematic review. Ophthalmology. 2003;110(9):1789–98.

    Article  PubMed  Google Scholar 

  53. Huang FC, Tseng SH, Shih MH, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology. 2002;109(10):1934–40.

    Article  PubMed  Google Scholar 

  54. Puell MC, Benítez-del-Castillo JM, Martínez-de-la-Casa J, et al. Contrast sensitivity and disability glare in patients with dry eye. Acta Ophthalmol Scand. 2006;84(4):527–31.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Financial Disclosures: Dr. Farid is a consultant to AMO, Shire, Allergan, RPS, and TearScience.

Author information

Authors and Affiliations

  1. Gavin Herbert Eye Institute, UC-Irvine, 850 Health Sciences Road, Irvine, CA, 92697, USA

    Giancarlo A. Garcia MS & Marjan Farid MD

Authors
  1. Giancarlo A. Garcia MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marjan Farid MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marjan Farid MD .

Editor information

Editors and Affiliations

  1. Cornea Service, Illinois Eye and Ear Infirmary, Chicago, Illinois, USA

    Ali R. Djalilian

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Garcia, G.A., Farid, M. (2018). Management of Ocular Surface Disease in Cataract and Refractive Surgery Patients. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15823-5_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15822-8

  • Online ISBN: 978-3-319-15823-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation